Click below to learn more about some of our legislative activity in Washington.
Translating Discovery into Cures for Children with Cancer Childhood
Cancer Research Landscape Report - Executive Summary
Report of the BPCA/PREA Working Group
Alliance for Childhood Cancer - Remarks on Changes to the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA)
Appropriations for the National Institutes of Health and National Cancer Institute
H.R. 820/S. 292, The Childhood Cancer Survivorship, Treatment, Access, and Research (STAR) Act of 2017
Alliance for Childhood Cancer Letter to FDA RE: Response to Request for Comments following Public Workshop on Complex Issues in Developing Drug and Biological Products for Rare Diseases